Search for: "APOTEX V MERCK"
Results 21 - 40
of 117
Sorted by Relevance
|
Sort by Date
13 Dec 2010, 4:55 pm
The case, Apotex, Inc. v. [read post]
25 Mar 2007, 9:46 pm
The CAFC cited Merck, 874 F2d at 809. [read post]
27 Feb 2013, 9:53 pm
Merck Sharp & Dohme Corp. v. [read post]
5 Oct 2010, 2:58 pm
Circuit’s March 2, 2010 decision in Teva Pharms USA, Inc. v. [read post]
6 May 2007, 9:06 pm
Apotex Primaxin: Merck v. [read post]
25 Jan 2007, 7:16 pm
Barr Trusopt: Merck v. [read post]
3 Apr 2013, 4:45 am
But the recent split Federal Circuit panel decision in Momenta Pharmaceuticals, Inc. v. [read post]
2 Jul 2007, 2:51 pm
Teva Singulair: Merck Sharp & Dohme v. [read post]
25 May 2018, 8:34 am
” Merck & Co. v. [read post]
10 Sep 2013, 4:00 am
In a decision released in July, Merck & Co., Inc. v. [read post]
2 Apr 2007, 9:52 pm
Trusopt: Merck v. [read post]
18 May 2010, 3:19 pm
Circuit’s March 2, 2010 decision in Teva Pharms USA, Inc. v. [read post]
14 Nov 2016, 9:16 am
R. 50 JMOL motion) BPCIA – Notice of Commercial Marketing: Apotex Inc., et al. v. [read post]
6 Jul 2010, 11:03 am
See Apotex, Inc. v. [read post]
18 Aug 2006, 6:07 am
Merck: Experimental use; safe harbor Apotex v. [read post]
5 Mar 2024, 10:23 am
Apotex, Inc., 480 F.3d 1348 (Fed. [read post]
25 Apr 2010, 5:52 pm
Federal Trade Commission v. [read post]
3 Nov 2010, 1:21 am
No – discussion of patent-eligibility standards for genes (Patent Baristas) US: Appellees file reply brief in Therasense v Becton Dickinson (Patent Docs) US: Another Capitol Hill missive objects to the inclusion of patent settlement provisions in FY 2011 Appropriations Bill (FDA Law Blog) US: REMS and 180-day exclusivity forfeiture – some interesting disclosures to the SEC (FDA Law Blog) Products Botox (Botulinum) – EU: General Court upholds opposition to BOTUMAX Community… [read post]
15 Apr 2016, 4:00 am
https://t.co/yOydyyJdg0 -> Computer and Internet Updates for 2016-04-13 https://t.co/i1qoG2Y3HM -> Supreme Court denies leave to appeal in Merck v. [read post]
17 Nov 2007, 7:58 am
The conduct here was also arguably explainable, and did not rise to the necessary level to warrant setting aside the previous judgment.More detail of Apotex Corp. v. [read post]
